Asensus Surgical (FRA:2TX) Additional Paid-In Capital : €897.66 Mil(As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Asensus Surgical Additional Paid-In Capital?

Asensus Surgical's quarterly additional paid-in capital declined from Sep. 2023 (€909.78 Mil) to Dec. 2023 (€892.36 Mil) but then increased from Dec. 2023 (€892.36 Mil) to Mar. 2024 (€897.66 Mil).

Asensus Surgical's annual additional paid-in capital increased from Dec. 2021 (€844.86 Mil) to Dec. 2022 (€908.82 Mil) but then declined from Dec. 2022 (€908.82 Mil) to Dec. 2023 (€892.36 Mil).

Asensus Surgical Additional Paid-In Capital Historical Data

The historical data trend for Asensus Surgical's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asensus Surgical Additional Paid-In Capital Chart

Asensus Surgical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

648.44

642.31

844.86

908.82

892.36

Asensus Surgical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															900.53	891.93	909.78	892.36	897.66

Asensus Surgical Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Asensus Surgical Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Asensus Surgical's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Asensus Surgical (FRA:2TX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Asensus Surgical Inc (FRA:2TX) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

ASXC:USA

Address

1 TW Alexander Drive, Suite 160, Durham, NC, USA, 27703

Website

https://www.asensus.com

Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.

Asensus Surgical (FRA:2TX) Headlines

No Headlines